in this issue
Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients
Saltigo Opens cGMP Plant; Eyes Accelerated Growth
9:38 AM MST | February 25, 2008 | Natasha Alperowicz
Saltigo (Langenfeld, Germany), the wholly owned fine chemical subsidiary of Lanxess, has officially inaugurated a €10-million ($14.5 million), state-of-the-art cGMP custom manufacturing facility at Leverkusen and pledged to invest €50 million through 2009 to position the business for further growth. The four-module, multipurpose cGMP unit, dubbed O10, can produce more than 200 m.t./year of advanced pharmaceutical intermediates (API), registered intermediates, and starting compounds for the pharmaceutical industry. It adds about 25% to Saltigo’s...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee